Thanks TDA,
Not quite the news we wanted, but there's our reason I guess.
I've no idea what happens with approved generics, but perhaps Apotex get a bit of promotion from the gsk reps with clients they suspect they will lose.
It looks like we need some more "phase 2 stunning results" data!